These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34514537)

  • 21. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
    Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
    Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
    Rasool MF; Khalil F; Läer S
    Clin Pharmacokinet; 2015 Sep; 54(9):943-62. PubMed ID: 25773479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach.
    Brussee JM; Yu H; Krekels EHJ; Palić S; Brill MJE; Barrett JS; Rostami-Hodjegan A; de Wildt SN; Knibbe CAJ
    Pharm Res; 2018 Jul; 35(9):182. PubMed ID: 30062590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
    Alcorn J; McNamara PJ
    Clin Pharmacokinet; 2002; 41(12):959-98. PubMed ID: 12222995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of age-related changes in rodent liver morphology and physiology on drug metabolism--a review.
    van Bezooijen CF
    Mech Ageing Dev; 1984; 25(1-2):1-22. PubMed ID: 6727439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmics: elimination and dosage considerations in hepatic impairment.
    Klotz U
    Clin Pharmacokinet; 2007; 46(12):985-96. PubMed ID: 18027986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age and gender on the activity of human hepatic CYP3A.
    Hunt CM; Westerkam WR; Stave GM
    Biochem Pharmacol; 1992 Jul; 44(2):275-83. PubMed ID: 1642641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related pharmacokinetic changes of acetaminophen, antipyrine, diazepam, diphenhydramine, and ofloxacin in male cynomolgus monkeys and beagle dogs.
    Koyanagi T; Yamaura Y; Yano K; Kim S; Yamazaki H
    Xenobiotica; 2014 Oct; 44(10):893-901. PubMed ID: 24650193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic implications for the clinical use of propofol.
    Kanto J; Gepts E
    Clin Pharmacokinet; 1989 Nov; 17(5):308-26. PubMed ID: 2684471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of age upon liver volume and apparent liver blood flow in healthy man.
    Wynne HA; Cope LH; Mutch E; Rawlins MD; Woodhouse KW; James OF
    Hepatology; 1989 Feb; 9(2):297-301. PubMed ID: 2643548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The net weight of the rabbit liver and its relevance for asialoglycoprotein clearance.
    Regoeczi E; Chindemi PA
    Growth; 1981; 45(1):19-28. PubMed ID: 7227848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
    Wåhlander K; Eriksson-Lepkowska M; Frison L; Fager G; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):755-64. PubMed ID: 12846596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aging on hepatic elimination of cimetidine and subsequent interaction of aging and cimetidine on aminopyrine metabolism.
    Henderson GI; Speeg KV; Roberts RK; Perez A; Schenker S
    Biochem Pharmacol; 1988 Jul; 37(13):2667-73. PubMed ID: 3390226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.
    Woodhouse KW; Wynne HA
    Clin Pharmacokinet; 1988 Nov; 15(5):287-94. PubMed ID: 3203484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.
    Stader F; Kinvig H; Penny MA; Battegay M; Siccardi M; Marzolini C
    Clin Pharmacokinet; 2020 Mar; 59(3):383-401. PubMed ID: 31583609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.